Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytes1

Abstract

To examine the possibility of targeting liposomes to hepatocytes via bile salts, the bile salt lithocholyltaurine was covalently linked to a phospholipid. The isomeric compounds disodium 3α-(2-(1,2-O-distearoyl-sn-glycero-3-phospho-2′-ethanolamidosuccinyloxy)ethoxy)-5β-cholan-24-oyl-2′-aminoethansulfonate and disodium 3β-(2-(1,2-O-distearoyl-sn-glycero-3-phospho-2′-ethanolamidosuccinyloxy)ethoxy-5β-cholan-24-oyl-2′-aminoethansulfonate (DSPE-3β-LCT) were synthesized and incorporated into liposomal membranes. Confocal laser scanning microscopy studies showed that bile salt-bearing liposomes (BSLs) attach to the surface of rat hepatocytes in culture. Studies with radioactively labeled liposomes revealed that the bile salt linked via the 3β-conformation resulted in a higher attachment efficiency than that with the 3α-derivative. In the presence of BSLs corresponding to 2 mM liposomal phosphatidylcholine, uptake of 50 μM cholyltaurine (CT) into hepatocytes was reduced by ∼40% by the 3β-derivative and by ∼17% by the 3α-derivative. When added simultaneously with the liposomes, CT up to 75 μM inhibited the binding of DSPE-3β-LCT-bearing liposomes. By contrast, increasing concentrations reversed this inhibition and resulted in an increased bile salt-mediated binding. The same was true when CT was added 10 min before the liposomes were added.The attachment of BSLs to the surface of hepatocytes opens up promising possibilities for hepatocyte-specific drug delivery. More generally, not only substrates for cellular endocytosing receptors but also substrates for cellular carrier proteins should be suitable ligands for the cell-specific targeting of nanoscale particles such as liposomes.

Keywords

• hepatic drug delivery
• bile salt carrier
• modified liposomes
• hepatocyte-specific drug targeting